Long-Term Medication Usage After Bariatric Surgeries Compared
Patterns of medication use for obesity-related comorbidities slightly more favorable following gastric bypass versus sleeve gastrectomy
Thromboembolic Disorders
Adding a P2Y12 Inhibitor Does Not Improve Outcomes in COVID-19
Adding a P2Y12 inhibitor to a therapeutic dose of heparin does not improve outcomes among non-critically ill patients hospitalized for COVID-19
Device Malfunction Reports Prompt Recall of Embolic Protection System
The recall was initiated following reports of 9 device malfunctions.
Xarelto Approved to Treat and Prevent Blood Clots in Pediatric Patients
A new oral suspension formulation of Xarelto has also been approved by the FDA.
FDA Clears Neuromuscular Stimulation Device for Venous Insufficiency and Ischemia
The geko device is designed to stimulate the common peroneal nerve.
High Temperature Exposure Prompts Recall of Anticoagulant Med
Exposure to higher temperatures may have significantly impacted the efficacy of the recalled product.
Rates of Recurrent VTE Compared for Apixaban, Rivaroxaban
Among new users, rates of recurrent venous thromboembolism, GI and intracranial bleeding lower with apixaban than rivaroxaban
Rinvoq Labeling Updated to Include Class Warnings Related to JAK Inhibitors
The update follows the FDA’s Drug Safety Communication, which was based on a completed review of a large randomized safety clinical trial evaluating tofacitinib in patients with rheumatoid arthritis.
AHA: Oral Milvexian Promising for Prevention of VTE
In patients undergoing knee arthroplasty, postoperative incidence of venous thromboembolism lower with milvexian versus enoxaparin
AHA: Better Management of High Cholesterol Needed in Young Adults
A substantial number of young adults with moderate or severe hypercholesterolemia do not achieve guideline-directed reductions in LDL-C
